Lisa Shulman is director of autism clinical services at the Children’s Evaluation and Rehabilitation Center at Montefiore Medical Center in New York City.
Lisa Shulman
Director of autism clinical services
Children’s Evaluation and Rehabilitation Center, Montefiore Medical Center
From this contributor
How to help underserved groups gain access to autism care
Place your autism center in the community you serve, remove barriers to care, cast a wide net for autism signs, and do as much as possible in the first visit: These principles can help build a lifelong relationship with the community.
How to help underserved groups gain access to autism care
By
Lisa Shulman
15 January 2019 | 6 min read
Children who ‘recover’ from autism still struggle
Some children with autism lose their diagnosis over time, but still struggle with language, learning and anxiety, says Lisa Shulman.
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read